Clinical Trial Update: TH-302 Plus Doxorubicin Delivered by Trans-Arterial Chemoembolization (TACE) in Patients With Hepatocellular Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 trial update of TH-302 (evofosfamide) plus doxorubicin delivered via trans-arterial chemoembolization for hepatocellular carcinoma. The document lists t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• TH-302 (evofosfamide)

Snippet

Sponsor: Scripps Clinic Cancer Center | Conditions: Hepatocellular Carcinoma | Phase 1 | Status: UNKNOWN